Back to top
more

Molina Healthcare (MOH)

(Real Time Quote from BATS)

$295.09 USD

295.09
269,302

-10.91 (-3.57%)

Updated Nov 15, 2024 01:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Brookdale Senior (BKD) Shares Rise 1.9% Despite Q3 Earnings Miss

by Zacks Equity Research

Brookdale Senior (BKD) expects adjusted EBITDA to be within the $77-$82 million range in the fourth quarter.

Select Medical (SEM) Stock Down 6.6% Despite Q3 Earnings Beat

by Zacks Equity Research

Select Medical (SEM) continues to expect adjusted EBITDA to be between $795 million and $825 million in 2023.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cigna (CI) Q3 Earnings Beat on Membership Growth, '23 EPS View Up

by Zacks Equity Research

Cigna's (CI) Q3 results benefit on well-performing U.S. Commercial and Medicare Advantage businesses. Management currently expects 2023 adjusted EPS to be a minimum of $24.75.

Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit

by Zacks Equity Research

Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.

Molina (MOH) is an Incredible Growth Stock: 3 Reasons Why

by Zacks Equity Research

Molina (MOH) possesses solid growth attributes, which could help it handily outperform the market.

Encompass Health's (EHC) Q3 Earnings Beat on Discharge Growth

by Zacks Equity Research

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.

Molina Healthcare (MOH) Q3 Earnings Beat on Membership Growth

by Zacks Equity Research

Molina Healthcare's (MOH) third-quarter results gain from changes in the member mix and a growing premium base. Management reiterates its 2023 adjusted EPS guidance to be a minimum of $20.75.

Universal Health (UHS) Q3 Earnings Beat on Adjusted Patient Days

by Zacks Equity Research

Universal Health (UHS) has a leftover repurchase capacity of around $580 million as of Sep 30, 2023.

Here's What Key Metrics Tell Us About Molina (MOH) Q3 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Molina (MOH) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 3.70% and 2.94%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised

by Zacks Equity Research

Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Will the Medicare Unit Aid Molina Healthcare's (MOH) Q3 Earnings?

by Zacks Equity Research

Molina Healthcare's (MOH) Q3 results are expected to benefit on growing premiums and an expanding customer base within its Medicaid and Medicare businesses, partly offset by increased medical costs.

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Market: Novo Nordisk, Amgen, Fabrinet in Focus

by Abhinab Dasgupta

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Here's Why Molina (MOH) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

UnitedHealth Group's (UNH) Arm OptumRx Expands in Arizona

by Zacks Equity Research

UnitedHealth Group (UNH) is set to enhance the offerings of OptumRx with the recent expansion of pharmacy care services in Arizona.

Should Value Investors Buy Molina Healthcare (MOH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights Stride, Deckers Outdoor, Molina Healthcare and McKesson

by Zacks Equity Research

Stride, Deckers Outdoor, Molina Healthcare and McKesson have been highlighted in this Screen of The Week article.

Here's Why You Should Hold Centene (CNC) in Your Portfolio

by Zacks Equity Research

Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Sumit Singh headshot

4 Stocks That Flaunt an Impressive Interest Coverage Ratio

by Sumit Singh

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. LRN, DECK, MOH and MCK and are sound enough to meet financial obligations.

Centene (CNC) Eyes Membership Growth With 2024 Expansion Plans

by Zacks Equity Research

Centene (CNC) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.

If You Invested $1000 in Molina a Decade Ago, This is How Much It'd Be Worth Now

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Here's Why You Should Hold UnitedHealth Group (UNH) Stock Now

by Zacks Equity Research

Growing Membership, expanding government business, strategic acquisitions, improving operating margin and solid 2024 plans poise UnitedHealth Group (UNH) well for growth.

Here's Why Investors Should Retain Humana (HUM) Stock Now

by Zacks Equity Research

Humana (HUM) benefits from an upgraded health plan offering suite, expanding Medicare Advantage membership and solid cash reserves.